Paradeep Phosphates (PARADEEP) Q4 20/21 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 20/21 earnings summary
2 Nov, 2026Executive summary
FY2020-21 total income was ₹5,183.94 crore vs ₹4,227.78 crore; EBITDA rose to ₹561.46 crore from ₹494.66 crore, and PBT to ₹366.70 crore from ₹230.39 crore.
Growth plans centered on a proposed Goa fertilizer-plant acquisition for US$280 million enterprise value, subject to approvals, alongside capacity and efficiency projects.
Financial highlights
Revenue from operations was ₹5,164.73 crore vs ₹4,192.86 crore; other income declined to ₹19.21 crore from ₹34.91 crore.
Standalone PAT rose to ₹223.46 crore from ₹194.05 crore; total comprehensive income was ₹224.31 crore vs ₹190.64 crore.
Finance costs declined to ₹111.43 crore from ₹191.79 crore; depreciation and amortization increased to ₹83.33 crore from ₹72.48 crore.
Total expenses increased to ₹4,817.24 crore from ₹3,997.39 crore, including traded-goods purchases of ₹1,380.20 crore vs ₹475.41 crore.
Operating cash flow was ₹1,501.15 crore vs ₹1,269.74 crore; investing outflow was ₹289.32 crore and financing outflow ₹1,124.38 crore.
Outlook and guidance
A 400 TPD phosphoric acid plant using Prayon technology was in engineering and construction phases; management said it would reduce P₂O₅ imports.
The 4th evaporator project, with 350 TPD capacity, was expected to reach mechanical completion in July 2021.
A DAP plant train restarted after revamp in November 2020; the second train was expected to restart in May 2021.
Latest events from Paradeep Phosphates
- Profit improved as production volumes fell and working-capital needs drove operating cash outflow.PARADEEP
Q4 18/19 - Lower tax lifted FY20 profit despite weaker revenue and production.PARADEEP
Q4 19/20 - Higher volumes lifted FY22 profit as Goa acquisition and capacity expansion set the growth agenda.PARADEEP
Q4 21/22 - Capacity reached 3 MMTPA as revenue surged, while profit and returns fell.PARADEEP
Q4 22/23 - H1 revenue grew, but weaker profits and volumes left debt reduction reliant on Rabi sales.PARADEEP
Q2 26/27 - Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/27 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/26 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/26 - Net profit up 134.7% YoY in H1 FY26, driven by MCFL merger and major capacity expansion.PARADEEP
Q2 25/26